STOCKSCREENR
Log In

AMPH

NASDAQ

Amphastar Pharmaceuticals, Inc.

$19.51+0.10(+0.52%)Mkt Cap: $896.53M

Key Stats

Market Cap

$896.53M

P/E Ratio

9.61

EPS

$2.03

Dividend Yield

0.00%

52-Week Range

$17.03 — $31.26

Volume

595.92K

Avg Volume

457.17K

Beta

0.92

Valuation

P/E (TTM)

9.61

Forward P/E

5.40

PEG Ratio

-0.83

P/S (TTM)

1.21

P/B (TTM)

1.10

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

0.13%

ROA (TTM)

0.06%

ROIC

—

Gross Margin

0.49%

Operating Margin

0.20%

Net Margin

—

Debt/Equity

0.83

Current Ratio

4.02

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.37%

EPS Growth (5Y)

+8.55%

Sales Growth (3Y)

+0.19%

Sales Growth (5Y)

+0.18%

EPS Est (This Year)

$3.61

EPS Est (Next Year)

$3.79

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$6.16

Analyst Consensus

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

45.95M

Float

34.80M

Free Float %

75.74%

Technicals

RSI (14)

15.01

SMA 20

$24.81

SMA 50

$26.25

SMA 200

$25.83

ATR (14)

1.45

Volatility (Week)

0.03%

Volatility (Month)

0.06%

Pattern

—

Performance

1 Day

-0.91%

1 Week

-4.01%

1 Month

-34.95%

3 Months

-28.89%

6 Months

-34.95%

1 Year

—

YTD

-28.06%

All-Time High

$33.42

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

NASDAQ

IPO Date

2014-06-25

Employees

2028

CEO

Yongfeng Zhang

Index Membership

—

Website

https://www.amphastar.com

Amphastar Pharmaceuticals, Inc. (AMPH) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $896.53M, a P/E ratio of 9.61, AMPH is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AMPH against other stocks using dozens of fundamental and technical filters.

Similar Stocks

WEED.TO

Canopy Growth Corporation

$1.48

+7.25%

$268.98M

PRGO

Perrigo Company plc

$10.30

+5.97%

$1.42B

PCRX

Pacira BioSciences, Inc.

$21.94

-3.31%

$943.89M

IRWD

Ironwood Pharmaceuticals, Inc.

$3.25

-3.56%

$529.94M

ALVO

Alvotech

$3.82

+5.82%

$1.19B

INDV

Indivior Pharmaceuticals Inc

$31.33

+1.16%

$3.91B

Frequently Asked Questions

What is Amphastar Pharmaceuticals, Inc.'s P/E ratio?

Amphastar Pharmaceuticals, Inc. (AMPH) has a trailing twelve-month (TTM) P/E ratio of 9.61. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Amphastar Pharmaceuticals, Inc. pay a dividend?

No, Amphastar Pharmaceuticals, Inc. (AMPH) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Amphastar Pharmaceuticals, Inc.'s market cap?

Amphastar Pharmaceuticals, Inc. (AMPH) has a market capitalization of $896.53 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has AMPH performed this year?

Amphastar Pharmaceuticals, Inc. (AMPH) has returned -28.06% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.